Crouse Health is the first hospital in Central New York to use the Watchman device, a minimally invasive implant approved by the U.S. Food and Drug Administration as an alternative to long-term blood thinner therapy for patients with atrial fibrillation (AFib), a common heart rhythm disorder. Studies have shown that the Watchman device offers patients…
